Neuropsychobiology
Pharmacoelectroencephalography. Main Editor: W.M. Herrmann (Berlin) / Original Paper
Appearance of Frontal Midline Theta Activity in Patients with Generalized Anxiety DisorderSuetsugi M.a · Mizuki Y.b · Ushijima I.b · Kobayashi T.a · Tsuchiya K.a · Aoki T.a · Watanabe Y.aaDepartment of Neuropsychiatry, Yamaguchi University School of Medicine, Ube, and bShimonoseki Hospital of Mental and Nervous Disorders, Shimonoseki, Japan
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: January 21, 2000
Issue release date: January 2000
Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 3
ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)
For additional information: https://www.karger.com/NPS
Abstract
The appearance of frontal midline theta activity (Fmθ), recognized as distinct EEG theta rhythm in the frontal midline area during performance of a mental task, reflects feelings of relief from anxiety in humans. In the present study, EEGs were recorded, and the Hamilton Rating Scale for Anxiety and the state anxiety scale of Spielberger’s State-Trait Anxiety Inventory were evaluated once a week in 28 patients with generalized anxiety disorder. The Taylor Manifest Anxiety Scale and the trait anxiety scale of Spielberger’s State-Trait Anxiety Inventory were used to assess anxiety before and after the tests. The present results suggest that the appearance of Fmθ might be closely related to an improvement in the anxiety symptoms associated with generalized anxiety disorder.
© 2000 S. Karger AG, Basel
Related Articles:
References
- Ishihara T, Yoshii N: Multivariate analytic study of EEG and mental activity in juvenile delinquents. Electroencephalogr Clin Neurophysiol 1972;33:71–80.
- Mizuki Y, Kajimura N, Nishikori S, Imaizumi J, Yamada M: Appearance of frontal midline theta rhythm and personality traits. Folia Psychiatr Neurol Jpn 1984;38:451–458.
- Mizuki Y, Hamasaki J, Hirano H, Miyoshi A, Yamada M, Inanaga K: Effects of centrally acting drugs on the frontal midline theta activity in man. Jpn J Psychiatr Neurol 1986;40:647–653.
- Mizuki Y, Suetsugi M, Imai T, Kai S, Kajimura N, Yamada M: A physiological marker for assessing anxiety level in humans: Frontal midline theta activity. Jpn J Psychiatr Neurol 1989;43:619–626.
- Mizuki Y, Suetsugi M, Ushijima I, Yamada M: Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety. Prog Neuropsychopharmacol Biol Psychiatr 1996;20:1353–1367.
- Mizuki Y, Suetsugi M, Ushijima I, Yamada M: Differential effects of dopaminergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety. Prog Neuropsychopharmacol Biol Psychiatry 1997;21:573–590.
- Suetsugi M, Mizuki Y, Ushijima I, Yamada M: Anxiolytic effects of low-dose clomipramine in highly anxious healthy volunteers assessed by frontal midline theta activity. Prog Neuropsychopharmacol Biol Psychiatry 1998;22:97–112.
- Mizuki Y, Suetsugi M, Ushijima I, Yamada M: Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity. Method Find Exp Clin 1994;16:291–300.
- Nutt DJ: The pharmacology of human anxiety. Pharmacol Ther 1990;47:233–266.
-
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
-
Kuraishi S, Kato M, Tsujioka B: Development of the Uchida-Kraepelin psychodiagnostic test in Japan. Psychologia 1985;14:235–240.
-
Taylor JA: Drive theory and manifest anxiety. Psychol Bull 1956;53:303–320.
-
Spielberger CD, Gorsuch RL, Lushene RE: State-Trait Anxiety Inventory. Palo Alto, Consulting Psychologists Press, 1970.
- Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–55.
- Kuwahara H, Higashi H, Mizuki Y, Matsunari S, Tanaka M, Inanaga K: Automatic real-time analysis of human sleep stages by an interval histogram method. Electroencephalogr Clin Neurophysiol 1988;70:220–229.
-
Pratt JA: The neuroanatomical basis of anxiety. Pharmacol Ther 1993;55:149–181.
-
Walker LG: The measurement of anxiety. Postgrad Med J 1990;66:11–17.
- Stein MB, Uhde TW: Infrequent occurrence of EEG abnormalities in panic disorders. Am J Psychiatry 1989;146:517–520.
- Lepola U, Nousiainen U, Puranen M, Riekkinen P, Rimon R: EEG and CT findings in patients with panic disorder. Biol Psychiatry 1990;28:721–727.
- Gevins A, Smith ME, McEvoy L, Yu D: High-resolution EEG mapping of cortical activation related to working memory: Effects of task difficulty, type of processing, and practice. Cereb Cortex 1997;7:374–385.
-
Eysenck HJ: Activation, arousal, and emotion; in Charles C (ed): The Biological Basis of Personality. Springfield, Thomas, 1967, pp 226–262.
-
Slater E, Roth M: Personality deviations and neurotic reactions; in Salter E, Roth M (eds): Clinical Psychiatry. Palo Alto, Consulting Psychologists Press, 1979, pp 56–187.
- Nutt DJ: The pharmacology of human anxiety. Pharmacol Ther 1990;47:233–266.
- Davidson JM: The physiology of medication and mystical states of consciousness. Perspect Biol Med 1976;19:345–379.
Article / Publication Details
Published online: January 21, 2000
Issue release date: January 2000
Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 3
ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)
For additional information: https://www.karger.com/NPS
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
